미국의 환자 자세 유지 및 보조 기구 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 부문별 예측(2026-2033년)

U.S. Patient Positioning And Support Aids Market Summary

The U.S. patient positioning and support aids market size was estimated at USD 559.94 million in 2025 and is projected to reach USD 959.44 million by 2033, growing at a CAGR of 6.6% from 2026 to 2033. Increasing volume of surgical procedures, the growing elderly population, and advancements in healthcare infrastructure.

As the aging population rises, the prevalence of chronic diseases and conditions requiring surgical interventions, such as joint replacements and cardiovascular procedures, also increases. This drives demand for effective patient positioning and support aids to ensure safety, comfort, and optimal access during procedures. The increasing number of surgical procedures is expected to boost the demand for U.S. patient positioning and support aids. The surgeries require positioning and support aids such as fluidized positioners, gel positioners, pillows, wedges, transfer aids, repositioning products, turning systems, slide sheets, and offloading devices to prevent the patient from pressure ulcers and to move the patient from one area to another area post-surgical procedures. Various surgical procedures, such as orthopedic, neurosurgeries, and cosmetic surgeries, are being carried out. According to World Population Review, approximately 2 million surgical procedures were performed in the United States in 2024.

The figure below presents the total number of surgical procedures performed in the U.S. in 2023 and 2024, highlighting the increase in surgical volume over the period.

In addition, diagnostic tests such as echocardiograms, cardiac catheterizations, and imaging studies such as CT and MRI scans rely on effective patient positioning to provide precise, accurate results. The increasing adoption of minimally invasive techniques and robotic-assisted surgeries in cardiology further boosted the need for advanced positioning aids designed for precision and stability. Moreover, the aging population, which is more susceptible to CVD, contributes to a rising demand for these aids in hospital and ambulatory care settings. The focus on reducing pressure injuries, optimizing comfort, and adhering to stringent safety standards further supports the growth of this market segment. According to the American Health Association, in 2024, there were 931,578 cardiovascular disease deaths in the U.S. This was an increase of less than 3,000 from the previous year. The age-adjusted death rate for CVD in 2024 was 233.3 per 100,000, which was a 4.0% increase from 2023.

Furthermore, the increasing number of orthopedic surgeries, such as hip and knee replacement surgeries that need U.S. patient positioning and support aids, is anticipated to propel market growth over the forecast period. According to data published by the American College of Rheumatology in February 2024, about 544,000 hip and 790,000 total knee replacements are performed annually in the U.S.

For instance, according to the American Academy of Orthopaedic Surgeons, in November 2024, the American Joint Replacement Registry (AJRR) surpassed 4 million captured hip and knee arthroplasty procedures, reflecting the growing volume of joint replacement surgeries in the United States.

"Surpassing 4 million captured hip and knee arthroplasty procedures solidifies AJRR's status as the largest orthopaedic registry by annual procedure count. This achievement reflects our collective commitment to improving patient care and gathering data that can influence the quality and effectiveness of treatments across the nation. The success of the AJRR wouldn't be possible without the support and contributions of our participating sites, surgeons and industry partners." said James I. Huddleston, III, MD, FAAOS, chair of the AJRR Steering Committee.

Rising awareness about patient safety is a key factor driving the growth of the U.S. patient positioning and support aids market. As healthcare professionals and patients become more aware of how to prevent injuries during patient handling, the demand for innovative and effective solutions that ensure safety and comfort increases. Improper patient handling can lead to pressure injuries for patients and musculoskeletal disorders among healthcare workers. To address this, industry stakeholders are publishing knowledge articles to improve understanding of proper patient handling and raising awareness about the safety of patients and healthcare workers. For instance, the American Nurses Association (ANA) is working to create a safer environment for nurses through its Safe Patient Handling and Mobility (SPHM) programs and advocacy efforts.

In addition, in December 2024, Medline's Clinical Solutions Manager published an article on how ICU nurses can prevent work-related musculoskeletal disorders. These articles and programs raise awareness about patient positioning and safety, which is expected to boost market growth over the forecast period.

Moreover, companies are launching patient positioning equipment that enhances patient and staff safety. For instance, in February 2024, Xodus Medical introduced two innovative variations of its lift-free patient positioning instrument, the Pink Pad Air-Assist. It includes the launch of the Pink Pad Air-Assist Trendelenburg + and the Pink Pad Air-Assist EXT + Trendelenburg.

U.S. Patient Positioning And Support Aids Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. patient positioning and support aids market report based on product and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Gel and Foam Positioners
  • Reusable Gel Positioners
  • Disposable Foam Positioners
• Pillows and Wedges
  • Bed Wedge
  • Positioning Pillows
• Sling-Based Positioning Aids
• Repositioning and Turning Systems
• Air-Assisted Transfer Aids
• Offloading Devices and Suspension Boots
• Slide Sheets
• Fluidized Positioners
  • Fluidized Positioners
  • Flo-Lock Filtered Positioners
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Rehabilitation Centers
• Nursing Homes
• Home Healthcare
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Patient Positioning and Support Aids Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing number of surgical procedures
    • 3.2.1.2. Innovations in medical technology
    • 3.2.1.3. Rising awareness about patient safety
    • 3.2.1.4. Growing prevalence of chronic and lifestyle associated diseases
    • 3.2.1.5. Increasing burden of hospital acquired infection
    • 3.2.1.6. Growing preterm births
    • 3.2.1.7. Rising incidence of pressure injuries and foot ulcers
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recalls
    • 3.2.2.2. High cost associated with equipment
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Rising focus on environment friendly and sustainable products
    • 3.2.3.2. Growing elderly population
    • 3.2.3.3. Increasing number of road accidents
    • 3.2.3.4. Development of low cost/ cost effective products
    • 3.2.3.5. Consumer preference for infection prevention products
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Intense competition
• 3.3. U.S. Patient Positioning and Support Aids Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining Power Of Suppliers
    • 3.3.1.2. Bargaining Power Of Buyers
    • 3.3.1.3. Threat Of Substitutes
    • 3.3.1.4. Threat Of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological Landscape

Chapter 4. U.S. Patient Positioning and Support Aids Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Patient Positioning and Support Aids Market Movement Analysis
• 4.3. U.S. Patient Positioning and Support Aids Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Gel and foam positioners
  • 4.4.1. Gel and Foam Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Reusable Gel Positioners
    • 4.4.2.1. Reusable Gel Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Disposable Foam Positioners
    • 4.4.3.1. Disposable Foam Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Pillows and Wedges
  • 4.5.1. Pillows and Wedges U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Bed Wedge
    • 4.5.2.1. Bed Wedge U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Positioning Pillows
    • 4.5.3.1. Positioning Pillows U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Sling-Based Positioning Aids
  • 4.6.1. Sling-Based Positioning Aids U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Repositioning and Turning Systems
  • 4.7.1. Repositioning and Turning Systems U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Air-Assisted Transfer Aids
  • 4.8.1. Air-Assisted Transfer Aids U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Offloading Devices and Suspension Boots
  • 4.9.1. Offloading Devices and Suspension Boots U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Slide Sheets
  • 4.10.1. Slide Sheets U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Fluidized Positioners
  • 4.11.1. Fluidized Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.2. Flo Fluidized Positioners
    • 4.11.2.1. Flo Fluidized Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11.3. Flo-Lock Filtered Positioners
    • 4.11.3.1. Flo-Lock Filtered Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Others
  • 4.12.1. Others U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Patient Positioning and Support Aids Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Patient Positioning and Support Aids Market Movement Analysis
• 5.3. U.S. Patient Positioning and Support Aids Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Rehabilitation Centers
  • 5.5.1. Rehabilitation Centers U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Nursing Homes
  • 5.6.1. Nursing Homes U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Home Healthcare
  • 5.7.1. Home Healthcare U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company/Competition Categorization
• 6.2. Strategy Mapping
• 6.3. Company Market Position Analysis, 2025
• 6.4. List of Key Certification Providers/Scheme Owners
• 6.5. Company Profiles/Listing
  • 6.5.1. Spry
    • 6.5.1.1. Company overview
    • 6.5.1.2. Financial performance
    • 6.5.1.3. Product Type benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Medline Industries, LP
    • 6.5.2.1. Company overview
    • 6.5.2.2. Financial performance
    • 6.5.2.3. Product Type benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Arjo
    • 6.5.3.1. Company overview
    • 6.5.3.2. Financial performance
    • 6.5.3.3. Product Type benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. EHOB
    • 6.5.4.1. Company overview
    • 6.5.4.2. Financial performance
    • 6.5.4.3. Product Type benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. DeRoyal Industries, Inc.
    • 6.5.5.1. Company overview
    • 6.5.5.2. Financial performance
    • 6.5.5.3. Product Type benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. Etac AB
    • 6.5.6.1. Company overview
    • 6.5.6.2. Financial performance
    • 6.5.6.3. Product Type benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. Hillrom (Baxter)
    • 6.5.7.1. Company overview
    • 6.5.7.2. Financial performance
    • 6.5.7.3. Product Type benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Guldmann
    • 6.5.8.1. Company overview
    • 6.5.8.2. Financial performance
    • 6.5.8.3. Product Type benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. ANSELL LTD
    • 6.5.9.1. Company overview
    • 6.5.9.2. Financial performance
    • 6.5.9.3. Product Type benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. Molnlycke Health Care AB
    • 6.5.10.1. Company overview
    • 6.5.10.2. Financial performance
    • 6.5.10.3. Product Type benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Stryker
    • 6.5.11.1. Company overview
    • 6.5.11.2. Financial performance
    • 6.5.11.3. Product Type benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Soule Medical
    • 6.5.12.1. Company overview
    • 6.5.12.2. Financial performance
    • 6.5.12.3. Product Type benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. STERIS
    • 6.5.13.1. Company overview
    • 6.5.13.2. Financial performance
    • 6.5.13.3. Product Type benchmarking
    • 6.5.13.4. Strategic initiatives
  • 6.5.14. Cardinal Health
    • 6.5.14.1. Company overview
    • 6.5.14.2. Financial performance
    • 6.5.14.3. Product Type benchmarking
    • 6.5.14.4. Strategic initiatives
  • 6.5.15. Skytron, LLC
    • 6.5.15.1. Company overview
    • 6.5.15.2. Financial performance
    • 6.5.15.3. Product Type benchmarking
    • 6.5.15.4. Strategic initiatives
  • 6.5.16. CONMED Corporation
    • 6.5.16.1. Company overview
    • 6.5.16.2. Financial performance
    • 6.5.16.3. Product Type benchmarking
    • 6.5.16.4. Strategic initiatives
  • 6.5.17. Invacare Corporation
    • 6.5.17.1. Company overview
    • 6.5.17.2. Financial performance
    • 6.5.17.3. Product Type benchmarking
    • 6.5.17.4. Strategic initiatives
  • 6.5.18. Drive DeVilbiss Healthcare
    • 6.5.18.1. Company overview
    • 6.5.18.2. Financial performance
    • 6.5.18.3. Product Type benchmarking
    • 6.5.18.4. Strategic initiatives
  • 6.5.19. GF Health Products (Graham-Field)
    • 6.5.19.1. Company overview
    • 6.5.19.2. Financial performance
    • 6.5.19.3. Product Type benchmarking
    • 6.5.19.4. Strategic initiatives
  • 6.5.20. AliMed
    • 6.5.20.1. Company overview
    • 6.5.20.2. Financial performance
    • 6.5.20.3. Product Type benchmarking
    • 6.5.20.4. Strategic initiatives
  • 6.5.21. Joerns Healthcare (MasVida)
    • 6.5.21.1. Company overview
    • 6.5.21.2. Financial performance
    • 6.5.21.3. Product Type benchmarking
    • 6.5.21.4. Strategic initiatives
  • 6.5.22. Savaria Corporation
    • 6.5.22.1. Company overview
    • 6.5.22.2. Financial performance
    • 6.5.22.3. Product Type benchmarking
    • 6.5.22.4. Strategic initiatives
  • 6.5.23. Blue Chip Medical Products
    • 6.5.23.1. Company overview
    • 6.5.23.2. Financial performance
    • 6.5.23.3. Product Type benchmarking
    • 6.5.23.4. Strategic initiatives
  • 6.5.24. Permobil group (Investor AB)
    • 6.5.24.1. Company overview
    • 6.5.24.2. Financial performance
    • 6.5.24.3. Product Type benchmarking
    • 6.5.24.4. Strategic initiatives
  • 6.5.25. Mizuho OSI (State Street)
    • 6.5.25.1. Company overview
    • 6.5.25.2. Financial performance
    • 6.5.25.3. Product Type benchmarking
    • 6.5.25.4. Strategic initiatives
  • 6.5.26. Smith & Nephew
    • 6.5.26.1. Company overview
    • 6.5.26.2. Financial performance
    • 6.5.26.3. Product Type benchmarking
    • 6.5.26.4. Strategic initiatives
  • 6.5.27. Xodus Medical Inc.
    • 6.5.27.1. Company overview
    • 6.5.27.2. Financial performance
    • 6.5.27.3. Product Type benchmarking
    • 6.5.27.4. Strategic initiatives